Published in EMBO Rep on March 31, 2017
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47
CRISPR provides acquired resistance against viruses in prokaryotes. Science (2007) 29.74
Small CRISPR RNAs guide antiviral defense in prokaryotes. Science (2008) 17.79
Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol (2011) 17.11
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A (2012) 16.48
EMAN2: an extensible image processing suite for electron microscopy. J Struct Biol (2006) 14.70
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature (2010) 14.21
CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science (2008) 11.82
RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell (2009) 11.12
Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology (2005) 10.20
CRISPR-based adaptive immune systems. Curr Opin Microbiol (2011) 8.07
The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics (2007) 7.34
Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. Genes Dev (2008) 7.09
Structural basis for CRISPR RNA-guided DNA recognition by Cascade. Nat Struct Mol Biol (2011) 6.02
Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature (2010) 5.89
CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol Cell (2012) 4.84
Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system. EMBO J (2011) 3.81
An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol (2015) 3.74
Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat Rev Microbiol (2014) 3.48
Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity. Mol Cell (2012) 3.41
Programmable RNA recognition and cleavage by CRISPR/Cas9. Nature (2014) 2.33
Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity. Cell (2015) 2.16
Structure of the CRISPR interference complex CSM reveals key similarities with cascade. Mol Cell (2013) 1.74
Cas9 specifies functional viral targets during CRISPR-Cas adaptation. Nature (2015) 1.70
The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature (2016) 1.64
Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting. Nature (2014) 1.46
RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus. Mol Cell (2014) 1.32
Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus. Mol Cell (2014) 1.30
Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system. J Bacteriol (2013) 1.22
An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference. Nucleic Acids Res (2014) 1.19
Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex. Genes Dev (2014) 1.18
Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems. Science (2016) 1.17
Structural model of a CRISPR RNA-silencing complex reveals the RNA-target cleavage activity in Cmr4. Mol Cell (2014) 1.14
Structural basis for promiscuous PAM recognition in type I-E Cascade from E. coli. Nature (2016) 1.05
Crystal Structure of a Transcribing RNA Polymerase II Complex Reveals a Complete Transcription Bubble. Mol Cell (2015) 1.01
Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog. Mol Cell (2015) 0.97
Crystal structure of the Csm1 subunit of the Csm complex and its single-stranded DNA-specific nuclease activity. Structure (2015) 0.92
Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR-Cas system. Genes Dev (2016) 0.86
RNA-activated DNA cleavage by the Type III-B CRISPR-Cas effector complex. Genes Dev (2016) 0.84
Spatiotemporal Control of Type III-A CRISPR-Cas Immunity: Coupling DNA Degradation with the Target RNA Recognition. Mol Cell (2016) 0.82
Multiple nucleic acid cleavage modes in divergent type III CRISPR systems. Nucleic Acids Res (2016) 0.82
Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes. Mol Cell (2015) 0.81
Identification and functional study of type III-A CRISPR-Cas systems in clinical isolates of Staphylococcus aureus. Int J Med Microbiol (2016) 0.80
Structural features of Cas2 from Thermococcus onnurineus in CRISPR-cas system type IV. Protein Sci (2016) 0.77
Crystal structure of the fungal nitroreductase Frm2 from Saccharomyces cerevisiae. Protein Sci (2015) 0.75
Arabidopsis FRIGIDA stimulates EFS histone H3 Lys36 methyltransferase activity. Plant Cell Rep (2017) 0.75
In vivo genome editing using the Cpf1 ortholog derived from Eubacterium eligens. Sci Rep (2019) 0.75